Description
Indication & Scope
XinTuoTuo®/Crestor® Rosuvastatin Calcium Tablets provides primary hypercholesterolemia and mixed dyslipidemia with poor blood lipid control via diet adjustment alone.
- Mechanism: Selectively inhibits hydroxymethylglutaryl coenzyme A reductase, blocks endogenous cholesterol synthesis, reduces blood total cholesterol, low-density lipoprotein and triglyceride levels, and increases high-density lipoprotein.
- Drug class: Statins lipid-lowering agent, cholesterol synthesis inhibitor.
- Clinical use: Long-term lipid regulation for primary hypercholesterolemia and mixed dyslipidemia unresponsive to dietary intervention.
| Generic Name | Rosuvastatin Calcium Tablets |
| Brand Name | XinTuoTuo®; Crestor® |
| Ingredient | Rosuvastatin Calcium |
| Dosage Form | Tablets |
| Package | XinTuoTuo:
10mg (calculated by Rosuvastatin C₂₂H₃₀FN₃O₆S)*14 tablets*2 blisters/box; 5mg (calculated by Rosuvastatin C₂₂H₃₀FN₃O₆S) (quantity to be determined) Crestor: 10mg*7 tablets*1 blister/box; 10mg*7 tablets*4 blister/box; 10mg*14 tablets*1 blister/box; 10mg*14 tablets*2 blister/box; 10mg*14 tablets*7 blister/box; 5mg*7 tablets*1 blister/box; 5mg*7 tablets*4 blister/box; 5mg*14 tablets*1 blister/box; 5mg*14 tablets*2 blister/box; 5mg*14 tablets*7 blister/box; 20mg*7 tablets*1 blister/box; 20mg*7 tablets*4 blister/box; 20mg*14 tablets*1 blister/box; 20mg*14 tablets*2 blister/box; 20mg*14 tablets*7 blister/box |
| Conditions Treated | Primary hypercholesterolemia, mixed blood lipid abnormality |
| Taboos | Hypersensitivity to rosuvastatin calcium; active liver disease or persistent abnormal liver function indexes; severe renal insufficiency; pregnancy and lactation |
| Place of origin | China; CARR 188 Lote 17, San Isidro Industrial Park, PO Box 1624, Canovanas, PR 00729, Puerto Rico |
| Prescription type | Prescription-only |
| Storage Conditions | Store at room temperature, keep sealed, protect from light and moisture |
| Manufacturer | Nanjing CHIA TAI TIANQING Pharmaceutical Co., Ltd.; IPR Pharmaceuticals, INCORPORATED |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20080669; H20080670; HJ20160545; HJ20160546; HJ20160611 |
| Approval Date | Mar 30, 2023; Jan 4, 2026 |
| Shelf Life | 36 months |
How to use ?
Recommended Dose: 5mg to 10mg once daily for initial treatment, dosage adjustable according to blood lipid test results.
Time: Once daily, bedtime administration is preferred for optimal lipid-lowering efficacy.
Instructions for use: Swallow whole with water, combine with low-fat diet during medication, review liver function and blood lipids regularly.
Interaction: Combination with fibrate lipid-lowering drugs increases myopathy risk; cyclosporine elevates rosuvastatin blood concentration.
Side effects:
1. Common: mild myalgia, headache, gastrointestinal discomfort.
2. Rare: liver function abnormality, rhabdomyolysis, renal damage.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What kind of blood lipid problems require Rosuvastatin Calcium Tablets treatment?
It treats primary hypercholesterolemia and mixed dyslipidemia uncontrolled by diet alone.
What administration time provides the best lipid-lowering effect of Rosuvastatin Calcium Tablets?
Fixed bedtime once-daily administration maximizes the drug’s cholesterol inhibition efficacy.
What organ function abnormality prohibits the use of Rosuvastatin Calcium Tablets?
Active liver disease, persistent abnormal liver function and severe renal insufficiency are contraindications.
What regular monitoring items are required during long-term medication of Rosuvastatin Calcium Tablets?
Regular blood lipid detection and liver function examination are essential for safe medication.
XinTuoTuo® | Rosuvastatin Calcium Tablets | Primary Hypercholesterolemia/Mixed Dyslipidemia | DengYueRX
INN: Rosuvastatin Calcium Tablets
Indications: Primary hypercholesterolemia and mixed dyslipidemia
Dosage Form: Tablets
Strength: 10mg (calculated by Rosuvastatin C₂₂H₃₀FN₃O₆S)/tablet
Price range: $3.49 through $32.89
